| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.05. | Theratechnologies Inc (2): Theratechnologies' TH1902 phase 1 data show efficacy | 1 | Stockwatch | ||
| 23.05. | Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors | 68 | GlobeNewswire (Europe) | Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable tolerability... ► Artikel lesen | |
| 09.05. | Theratechnologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 09.05. | Theratechnologies Inc (2): Theratechnologies holders elect 8 directors at meeting | 1 | Stockwatch | ||
| 09.05. | Theratechnologies Reports on its Annual Meeting of Shareholders | 1 | GlobeNewswire (USA) | ||
| 02.05. | Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting | 1 | GlobeNewswire (USA) | ||
| 15.04. | Theratechnologies Inc (2): Theratechnologies mails proxy circular for May 9 AGM | 2 | Stockwatch | ||
| 15.04. | Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders | 2 | GlobeNewswire (USA) | ||
| 15.04. | Theratechnologies Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.04. | Leede still bullish on Theratechnologies following "soft" quarter | 3 | Cantech Letter | ||
| 11.04. | Earnings call: Theratechnologies reports Q1 2024 sales decline, optimistic outlook | 1 | Investing.com | ||
| 11.04. | Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | 1 | GlobeNewswire (USA) | ||
| 10.04. | Theratechnologies Inc (2): Theratechnologies loses $4.48-million (U.S.) in Q1 | 1 | Stockwatch | ||
| 10.04. | Theratechnologies Inc reports results for the quarter ended in February - Earnings Summary | 1 | Reuters | ||
| 10.04. | Theratechnologies GAAP EPS of -$0.10 beats by $0.04, revenue of $16.2M misses by $3.19M | 3 | Seeking Alpha | ||
| 10.04. | Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024 | 145 | GlobeNewswire (Europe) | Q1 2024 consolidated revenue of $16.2 million Report marks third consecutive quarter of near-flat-to-positive Adjusted EBITDA1FY2024 revenue guidance confirmed between $87 and $90 million and an Adjusted... ► Artikel lesen | |
| 08.04. | Theratechnologies Inc (2): Theratechnologies presents preclinical data on SORT1+ | 1 | Stockwatch | ||
| 08.04. | Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology Oncology Platform | 1 | GlobeNewswire (USA) | ||
| 05.04. | Theratechnologies Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 05.04. | Theratechnologies Inc (2): Theratechnologies appoints Tea as director | 1 | Stockwatch |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 951 |
| GAMESTOP | 908 |
| TUI | 540 |
| NEL | 410 |
| EVOTEC | 343 |
| BAYER | 302 |
| DEUTSCHE LUFTHANSA | 259 |
| BYD | 227 |
| PLUG POWER | 204 |
| TESLA | 203 |
| RHEINMETALL | 197 |
| VOLKSWAGEN | 197 |
| DEUTSCHE TELEKOM | 193 |
| PAYPAL | 173 |
| BASF | 170 |
| PALANTIR TECHNOLOGIES | 163 |
| BIONTECH | 155 |
| VONOVIA | 154 |
| AMAZON | 153 |
| DWS GROUP | 153 |
| APPLE | 147 |
| AIXTRON SE | 135 |
| DEUTSCHE BANK | 135 |
| RWE | 135 |
| THYSSENKRUPP | 123 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
